Cargando…
Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch
Preformed donor-specific antibodies are associated with a higher risk of rejection and worse graft survival in organ transplantation. However, in heart transplantation, the risk and benefit balance between high mortality on the waiting list and graft survival may allow the acceptance of higher immun...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479575/ https://www.ncbi.nlm.nih.gov/pubmed/37675007 http://dx.doi.org/10.3389/fneph.2022.1047217 |
_version_ | 1785101620797767680 |
---|---|
author | Yamamoto, Takayuki Pearson, Daniel S. Ababneh, Emad I. Harris, Cynthia Nissaisorakarn, Pitchaphon Mahowald, Grace K. Heher, Yael K. Elias, Nahel Markmann, James F. Lewis, Gregory D. Riella, Leonardo V. |
author_facet | Yamamoto, Takayuki Pearson, Daniel S. Ababneh, Emad I. Harris, Cynthia Nissaisorakarn, Pitchaphon Mahowald, Grace K. Heher, Yael K. Elias, Nahel Markmann, James F. Lewis, Gregory D. Riella, Leonardo V. |
author_sort | Yamamoto, Takayuki |
collection | PubMed |
description | Preformed donor-specific antibodies are associated with a higher risk of rejection and worse graft survival in organ transplantation. However, in heart transplantation, the risk and benefit balance between high mortality on the waiting list and graft survival may allow the acceptance of higher immunologic risk donors in broadly sensitized recipients. Transplanting donor-recipient pairs with a positive complement dependent cytotoxic (CDC) crossmatch carries the highest risk of hyperacute rejection and immediate graft loss and is usually avoided in kidney transplantation. Herein we report the first successful simultaneous heart-kidney transplant with a T- and B-cell CDC crossmatch positive donor using a combination of rituximab, intravenous immunoglobulin, plasmapheresis, bortezomib and rabbit anti-thymocyte globulin induction followed by eculizumab therapy for two months post-transplant. In the year following transplantation, both allografts maintained stable graft function (all echocardiographic left ventricular ejection fractions ≥ 65%, eGFR>60) and showed no histologic evidence of antibody-mediated rejection. In addition, the patient has not developed any severe infections including cytomegalovirus or BK virus infection. In conclusion, a multitarget immunosuppressive regimen can allow for combined heart/kidney transplantation across positive CDC crossmatches without evidence of antibody-mediated rejection or significant infection. Longer follow-up will be needed to further support this conclusion. |
format | Online Article Text |
id | pubmed-10479575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104795752023-09-06 Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch Yamamoto, Takayuki Pearson, Daniel S. Ababneh, Emad I. Harris, Cynthia Nissaisorakarn, Pitchaphon Mahowald, Grace K. Heher, Yael K. Elias, Nahel Markmann, James F. Lewis, Gregory D. Riella, Leonardo V. Front Nephrol Nephrology Preformed donor-specific antibodies are associated with a higher risk of rejection and worse graft survival in organ transplantation. However, in heart transplantation, the risk and benefit balance between high mortality on the waiting list and graft survival may allow the acceptance of higher immunologic risk donors in broadly sensitized recipients. Transplanting donor-recipient pairs with a positive complement dependent cytotoxic (CDC) crossmatch carries the highest risk of hyperacute rejection and immediate graft loss and is usually avoided in kidney transplantation. Herein we report the first successful simultaneous heart-kidney transplant with a T- and B-cell CDC crossmatch positive donor using a combination of rituximab, intravenous immunoglobulin, plasmapheresis, bortezomib and rabbit anti-thymocyte globulin induction followed by eculizumab therapy for two months post-transplant. In the year following transplantation, both allografts maintained stable graft function (all echocardiographic left ventricular ejection fractions ≥ 65%, eGFR>60) and showed no histologic evidence of antibody-mediated rejection. In addition, the patient has not developed any severe infections including cytomegalovirus or BK virus infection. In conclusion, a multitarget immunosuppressive regimen can allow for combined heart/kidney transplantation across positive CDC crossmatches without evidence of antibody-mediated rejection or significant infection. Longer follow-up will be needed to further support this conclusion. Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC10479575/ /pubmed/37675007 http://dx.doi.org/10.3389/fneph.2022.1047217 Text en Copyright © 2022 Yamamoto, Pearson, Ababneh, Harris, Nissaisorakarn, Mahowald, Heher, Elias, Markmann, Lewis and Riella https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nephrology Yamamoto, Takayuki Pearson, Daniel S. Ababneh, Emad I. Harris, Cynthia Nissaisorakarn, Pitchaphon Mahowald, Grace K. Heher, Yael K. Elias, Nahel Markmann, James F. Lewis, Gregory D. Riella, Leonardo V. Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
title | Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
title_full | Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
title_fullStr | Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
title_full_unstemmed | Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
title_short | Case report: Successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
title_sort | case report: successful simultaneous heart-kidney transplantation across a positive complement-dependent cytotoxic crossmatch |
topic | Nephrology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479575/ https://www.ncbi.nlm.nih.gov/pubmed/37675007 http://dx.doi.org/10.3389/fneph.2022.1047217 |
work_keys_str_mv | AT yamamototakayuki casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT pearsondaniels casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT ababnehemadi casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT harriscynthia casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT nissaisorakarnpitchaphon casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT mahowaldgracek casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT heheryaelk casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT eliasnahel casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT markmannjamesf casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT lewisgregoryd casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch AT riellaleonardov casereportsuccessfulsimultaneousheartkidneytransplantationacrossapositivecomplementdependentcytotoxiccrossmatch |